ChemoCentryx Prices $45M IPO; Platforms, Partners Prevail
By Trista Morrison
Thursday, February 9, 2012
ChemoCentryx Inc. raised $45 million in its initial public offering (IPO), following Cempra Inc. and Verastem Inc. out an IPO window that, over the last few years, has proved selective at best.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.